Back to 
ROYAL BANK OF CANADA
ROYAL BANK OF CANADA
CNTB3 quarters
Position history for ROYAL BANK OF CANADA's holdings in CONNECT BIOPHARMA HLDGS LTD
Yes. Royal Bank of Canada holds 40,940 shares of CNTB (Connect Biopharma), worth $97,000, as of its Q2 2026 13F filing. It increased the position by 540 shares (+1.3%) from Q1 2026. Royal Bank of Canada has held CNTB since Q4 2025, across 3 quarterly 13F filings.
Current Value
$97,000
Current Shares
40,940
Total Value Change
-$17,000
Total Shares Change
+540
Quarter-by-Quarter History
Other major holders of CNTB: BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, MARSHALL WACE, LLP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC